The Medical Advisor

You’ve likely seen the claims: “Sugar feeds cancer — eliminate carbs.” “Keto starves tumors.” “Plant-based diets reverse cancer.” “Fasting kills cancer cells.” These ideas sound intuitive. Some are supported by laboratory or animal studies. Yet when tested rigorously in humans, most anti-cancer diet claims fail to show meaningful clinical benefit . This article explains why, what diet can realistically do for cancer risk and outcomes, and how nutrition fits into a modern, evidence-informed cancer strategy. 1. Lab Success Doesn’t Translate to Human Reality Many diet-based cancer claims originate from: Cell culture experiments Mouse models Short-term metabolic interventions In these controlled environments, researchers can deprive cancer cells of glucose or nutrients abruptly. Humans, however, are complex systems with: Multiple organs and hormones Immune responses Gut microbiomes Tumors that evolve and adapt What slows cancer growth in a dish often has minimal impact in real patients. R...

Introduction: A Broader View of Cancer Biology Traditional oncology often focuses on genetic mutations and targeted therapies. While mutations are critical, emerging research shows that cancer is also a disease of metabolic dysfunction and immune dysregulation. Understanding these systemic drivers can inform investigational therapies, repurposed drugs, and adjunctive strategies. This perspective — supported by researchers like Dr. Thomas Seyfried and others — sees cancer as a disorder rooted in metabolic dysfunction and immune evasion. ( One Day MD ) At OneDayMD, we analyze cancer using a mechanistic, evidence-based, and clinically cautious approach, highlighting metabolic and immune pathways that influence tumor growth, progression, and response to therapy. Keywords: cancer metabolism and immunity, metabolic immune disease of cancer, metabolic therapy explained Why Metabolic and Immune Perspectives Matter Cancer cells frequently rewire their energy systems: Dependence on glucose and ...

In 2022, Erica Eyres, a vigorous fifty-six-year-old aerobics instructor who had struggled to breathe, was given “absolutely devastating” news: She might need a lung transplant. She had never smoked, ran cross-country track in high school, and was a personal trainer for years, but, by 2024, a transplant assessment was arranged. (1) “I decided that I will make that decision,” she said, “only if it’s the last resort, and I’m on my deathbed.” A few months before her consultation, however, Eyres, then fifty-eight, made an appointment with a new primary care doctor for routine prescription refills. She was about to be introduced, literally and figuratively, to a new kind of medicine. It would change everything. DMSO Online Buying Guide (Paid Link) Buy on Amazon Disclosure: OneDayMD.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program that enables sites to earn advertising fees by advertising and linking to Amazon.com, but this is at NO extra co...